<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en-US">
	<id>https://www.insurerbrain.com/w/index.php?action=history&amp;feed=atom&amp;title=Definition%3AValue-based_insurance_design</id>
	<title>Definition:Value-based insurance design - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://www.insurerbrain.com/w/index.php?action=history&amp;feed=atom&amp;title=Definition%3AValue-based_insurance_design"/>
	<link rel="alternate" type="text/html" href="https://www.insurerbrain.com/w/index.php?title=Definition:Value-based_insurance_design&amp;action=history"/>
	<updated>2026-04-30T13:05:39Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.43.8</generator>
	<entry>
		<id>https://www.insurerbrain.com/w/index.php?title=Definition:Value-based_insurance_design&amp;diff=14073&amp;oldid=prev</id>
		<title>PlumBot: Bot: Creating new article from JSON</title>
		<link rel="alternate" type="text/html" href="https://www.insurerbrain.com/w/index.php?title=Definition:Value-based_insurance_design&amp;diff=14073&amp;oldid=prev"/>
		<updated>2026-03-13T13:40:22Z</updated>

		<summary type="html">&lt;p&gt;Bot: Creating new article from JSON&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;🏥 &amp;#039;&amp;#039;&amp;#039;Value-based insurance design&amp;#039;&amp;#039;&amp;#039; (VBID) is an approach to structuring [[Definition:Health insurance | health insurance]] benefits that aligns the cost a member pays for a service or treatment with the clinical value that service delivers, rather than applying uniform [[Definition:Cost sharing | cost-sharing]] levels across all categories of care. Rooted in health economics research, VBID challenges the traditional insurance design assumption that higher [[Definition:Deductible | deductibles]] and [[Definition:Copayment | copayments]] uniformly across all services will efficiently control costs. Instead, it recognizes that reducing financial barriers to high-value preventive care and chronic disease management can lower total [[Definition:Claim | claims]] costs over time, even if near-term utilization for those specific services increases.&lt;br /&gt;
&lt;br /&gt;
⚙️ In practice, a VBID program might reduce or eliminate [[Definition:Copayment | copayments]] for medications managing diabetes, hypertension, or asthma — conditions where medication adherence demonstrably prevents costly hospitalizations — while maintaining standard or elevated cost-sharing for low-value or elective services with limited clinical evidence. Insurers and [[Definition:Employer-sponsored insurance | employer plan sponsors]] implementing VBID rely on [[Definition:Actuarial analysis | actuarial modeling]] to project how changes in benefit structure affect utilization patterns, [[Definition:Medical loss ratio (MLR) | medical loss ratios]], and long-term claims trajectory. In the United States, Medicare Advantage plans have been authorized to test VBID models under demonstration programs administered by the Centers for Medicare &amp;amp; Medicaid Services, giving large [[Definition:Health insurance | health insurers]] a regulatory pathway to experiment with differential benefit structures. Outside the U.S., analogous concepts appear in markets like Singapore, where MediShield Life design emphasizes coverage for high-value inpatient care, and in supplemental health products in Europe that tier benefits by evidence-based clinical pathways.&lt;br /&gt;
&lt;br /&gt;
💡 For insurers, VBID represents both an opportunity and an analytical challenge. The opportunity lies in improved health outcomes that translate into lower [[Definition:Loss ratio | loss ratios]] over multi-year horizons — a particularly attractive dynamic for insurers with stable, long-tenure member populations. The challenge is that the return on investment is probabilistic and delayed: reducing cost barriers for a population of diabetics today may not produce measurable claims savings for two to five years, requiring carriers to accept short-term margin compression in exchange for longer-term profitability. [[Definition:Data analytics | Data analytics]] and [[Definition:Predictive modeling | predictive modeling]] capabilities are essential to identify which interventions deliver the strongest cost-value signal for a given population. As healthcare costs continue to rise globally and regulators push insurers toward demonstrating social value, VBID-oriented thinking is increasingly influencing [[Definition:Product development | product design]] well beyond the U.S. Medicare context.&lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Related concepts:&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
{{Div col|colwidth=20em}}&lt;br /&gt;
* [[Definition:Health insurance]]&lt;br /&gt;
* [[Definition:Medical loss ratio (MLR)]]&lt;br /&gt;
* [[Definition:Cost sharing]]&lt;br /&gt;
* [[Definition:Preventive care]]&lt;br /&gt;
* [[Definition:Actuarial analysis]]&lt;br /&gt;
* [[Definition:Employer-sponsored insurance]]&lt;br /&gt;
{{Div col end}}&lt;/div&gt;</summary>
		<author><name>PlumBot</name></author>
	</entry>
</feed>